Blood collection, components preparation and distribution in Iran, 2008-2012

Transfusion and Apheresis Science

Volumn 54, Issue 1, 2016, Pages 117-121

  Omidkhoda, Azadeh ^a,b   Amini Kafi Abad, Sedigheh ^b   Pourfatollah, Ali Akbar ^b,c   Maghsudlu, Mahtab ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Blood collection; Blood components; Blood distribution; Discard; Iran

Indexed keywords

FRESH FROZEN PLASMA; THROMBOCYTE CONCENTRATE;

ARTICLE; BLOOD COMPONENT; BLOOD DISTRIBUTION; BLOOD SAMPLING; BLOOD TRANSFUSION; COMPARATIVE STUDY; ERYTHROCYTE; HEALTH SURVEY; HEMATOLOGICAL PARAMETERS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; IRAN; NONHUMAN; PREVALENCE; APHERESIS; BLOOD DONOR; EPIDEMIOLOGY; GEOGRAPHY; HOSPITAL; HUMAN; STATISTICS AND NUMERICAL DATA; TRENDS; VIRUS;

BLOOD COMPONENT REMOVAL; BLOOD DONORS; BLOOD SPECIMEN COLLECTION; BLOOD TRANSFUSION; GEOGRAPHY; HOSPITALS; HUMANS; IRAN; PREVALENCE; VIRUSES;

EID: 84958280703     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2016.01.026     Document Type: Article

References (14)

1. Amini Kafi-abad S., Rezvan H., Abolghasemi H., Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009, 49:2214-2220.
2. Cheraghali A.M. Overview of blood transfusion system of Iran: 2002-2011. Iran J Public Health 2012, 41(8):89-93.
3. Maghsudlu M., Nasizadeh S., Abolghasemi H., Ahmadyar S.H. Blood donation and donor recruitment in Iran from 1998 through 2007: ten years' experience. Transfusion 2009, 49(11):2346-2351.
4. Cheraghali A.M. Blood safety concerns in the Eastern Mediterranean region. Hepat Mon 2011, 11(6):422-426.
5. Omidkhoda A., Abad S.A. Comparison of quality of red blood cells made from whole blood (after 8 and 24 hours holding time at 2-6 °C and 20-24 °C) in Iran. Blood Transfus 2014, 12(1):130-132.
6. Cheraghali A.M., Abolghasemi H. Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience. Hemophilia 2009, 15(2):487-493.
7. Jaff M.S. ABO and rhesus blood group distribution in Kurds. J Blood Med 2010, 1:143-146.
8. Keramati M.R., Shakibaei H., Kheiyyami M.I., Ayatollahi H., Badiei Z., Samavati M., et al. Blood group antigens frequencies in the northeast of Iran. Transfus Apher Sci 2011, 45(2):133-136.
9. Sullivan M.T., Cotten R., Read E.J., Wallace E.L. Blood collection and transfusion in the United States in 2001. Transfusion 2007, 47(3):385-394.
10. Faranoush M., Jalali F., Aminikafiabadi S., Balali M.R., Azarkeivan A., Hajibeigi B., et al. Haemovigilance in Iran (first report). Iran J Blood Cancer 2012, 1:7-11.
11. Bolton-Maggs P.H., Cohen H. Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Br J Haematol 2013, 163(3):303-314.
12. Oliver J.C., Griffin R.L., Hannon T., Marques M.B. The success of our patient blood management program depended on an institution-wide change in transfusion practices. Transfusion 2014, 54(10):2617-2624.
13. Edwards J., Morrison C., Mohiuddin M., Tchatalbachev V., Patel C., Schwickerath V.L., et al. Patient blood transfusion management: discharge hemoglobin level as a surrogate marker for red blood cell utilization appropriateness. Transfusion 2012, 52(11):2445-2451.
14. Mehra T., Seifert B., Bravo-Reiter S., Wanner G., Dutkowski P., Holubec T., et al. Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. Transfusion 2015, 55:2807-2815.